News
-
CD40 expression correlates with response to immunotherapy in melanoma patients
L-R: Ann Richmond, Chi Yan By Wendy Bindeman Ann Richmond, professor of pharmacology, and Chi Yan, a research assistant professor in the Richmond lab, recently published a study showing that expression of a protein called CD40 can be used to predict response to immunotherapy in malignant melanoma. Read MoreMar. 1, 2022
-
Jenkins named Basic Sciences diversity, equity, and inclusion program manager
By Wendy Bindeman Felysha Jenkins. The Vanderbilt University School of Medicine Basic Sciences recently welcomed Felysha Jenkins as its first Diversity, Equity, and Inclusion program manager. Basic Sciences is committed to fostering a diverse, inclusive environment that welcomes and supports trainees, faculty, and staff from all backgrounds. Throughout their long… Read MoreSep. 16, 2021
-
Scott Hiebert to serve as acting chair for the National Cancer Advisory Board
By Lorena Infante Lara Scott Hiebert, Hortense B. Ingram Chair in Cancer Research and professor of biochemistry, will serve as acting chair for the National Cancer Advisory Board. Originally appointed by President Barack Obama… Read MoreSep. 28, 2020